Skip to main content

160 RD203 (Propranolol Hydrochloride Extended-Release 160 mg)

Pill with imprint 160 RD203 is Brown, Capsule-shape and has been identified as Propranolol Hydrochloride Extended-Release 160 mg. It is supplied by Breckenridge Pharmaceutical, Inc.

Propranolol is used in the treatment of akathisia; angina; aortic stenosis; atrial fibrillation; arrhythmia and belongs to the drug classes group II antiarrhythmics, non-cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Propranolol 160 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 160 RD203

Propranolol hydrochloride extended-release 160 mg 160 RD203
Propranolol hydrochloride extended-release 160 mg 160 RD203
Propranolol hydrochloride extended-release 160 mg 160 RD203

Propranolol Hydrochloride Extended-Release

Imprint
160 RD203
Strength
160 mg
Color
Brown
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Group II antiarrhythmics, Non-cardioselective beta blockers
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0820
Inactive Ingredients
ethylcellulose (10 mPa.s), diethyl phthalate, titanium dioxide, ammonia, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, FD&C Blue No. 2, povidone k30, potassium hydroxide, hypromellose phthalate, sucrose, corn starch, polyethylene glycol 400

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.